JEFFREY M JONAS
CIK 1042021 · Chief Innovation Officer · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
56
Lifetime Open-Market Net
-$90.34M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CMPS | Director | — | $12.08 | — | $0 | 2 | 2026-05-29 |
| Generation Bio Co. (GBIO) Delisted | Director | — | $5.34 | — | $0 | 7 | 2026-02-09 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | 128,046 | $8.68 | $1.11M | -$82.05M | 36 | 2024-06-11 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | -$8.29M | 9 | 2024-03-18 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | Executive Vice President | — | — | — | $0 | 2 | 2008-01-04 |
Recent Filings · Page 5 of 6
56 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-10 | Sage Therapeutics, Inc. (SAGE) Delisted | Exer (M) | +10,000 | $4.5K | EDGAR |
| 2018-12-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-04 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-26 | Sage Therapeutics, Inc. (SAGE) Delisted | Exer (M) | +50,000 | $22.5K | EDGAR |
| 2017-12-22 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | −100,000 | -$35.02M | EDGAR |
| 2017-02-08 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-16 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-10 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-07 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +20,226 | $20.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.